546P Phase I study with expansion cohorts to assess the safety, tolerability, and activity of oral paclitaxel (oPac) + encequidar (E) in combination with pembrolizumab (Pem) in subjects with advanced solid malignancies

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; p. S609
Main Authors Ma, W.W., Singh, P., Manochakian, R., Yoon, H., Adjei, A.A., Lou, Y., Cutler, D., Landers, D., Chan, W-K., Zhi, J., Kwan, R.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2021
Online AccessGet full text
ISSN0923-7534
1569-8041
DOI10.1016/j.annonc.2021.08.1068

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.1068